Meanwhile, after knocking down the PD‐1 motif in human primary T cells using CRISPR/Cas9, CAR T cell cytokine production and cytotoxicity against PD‐L1‐expressing cancer cells were strongly enhanced. The gene discussed is CD274; the disease is cancer.